Champions Oncology (CSBR) Cash & Equivalents Growth (3y) (2013 - 2025)
Champions Oncology (CSBR) Cash & Equivalents Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
24.73% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
21.66% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Champions Oncology |
81.79 Mn |
74.79 Mn |
13.89 Mn |
- |
| Date | Value |
|---|
| Oct 31, 2025 |
-7.69% |
| Jan 31, 2025 |
-28.34% |
| Jul 31, 2024 |
-10.25% |
| Jul 31, 2023 |
-10.97% |
| Oct 31, 2022 |
57.25% |
| Jan 31, 2022 |
38.01% |
| Jul 31, 2021 |
57.90% |
| Jul 31, 2020 |
158.92% |
| Apr 30, 2020 |
36.29% |
| Jan 31, 2020 |
-2.01% |
| Oct 31, 2019 |
-13.68% |
| Jul 31, 2019 |
-20.98% |
| Apr 30, 2019 |
7.79% |
| Jan 31, 2019 |
0.17% |
| Jul 31, 2018 |
-46.83% |
| Apr 30, 2018 |
-54.94% |
| Jan 31, 2018 |
80.03% |
| Oct 31, 2017 |
6.78% |
| Jul 31, 2017 |
-60.96% |
| Apr 30, 2017 |
-17.61% |
